NCT02383927 · Interventional trial
Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations
Overall registry status Completed
Phase 2
Conditions HRAS Mutant Tumor, Other Squamous Cell Carcinoma (SCC) With HRAS Mutant Tumor, Squamous Cell Carcinoma Head and Neck Cancer (HNSCC), Thyroid Cancer
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory